Table of Contents Table of Contents
Previous Page  33 / 1851 Next Page
Information
Show Menu
Previous Page 33 / 1851 Next Page
Page Background

Cetuximab resistance

c) EGFR mutations in extracellular binding site inhibit cetuximab but not EGFR-ligand binding to EGFR

d) Cetuximab resistance can be mediated by activation of alternative signaling pathways

Mechanisms of Resistance to mAB